CRISPR Therapeutics AG
CRSPLatest QuantConomy context for CRSP: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.
CRISPR Therapeutics AG
QuantConomy has a structured record for CRSP. More descriptive asset metadata will appear here when the platform record includes it.
- Symbol
- CRSP
- Name
- CRISPR Therapeutics AG
- Coverage
- 3 market/data records
- Sources
- alpaca alphavantage fmp sec nasdaq lse
Recent signals for CRSP
Scored rows are pulled from the same signal API used by the digests.
| Signal | Direction | Score | Observed | Reason |
|---|---|---|---|---|
| volume spike | neutral | 41 | Jul 10, 05:52 PM | CRSP volume spike: 376% of expected volume for Friday 17:00 UTC, price flat 0.29% (strength 41) |
| dry up | neutral | 11 | Jul 10, 04:30 PM | CRSP volume dry-up: 25% of expected volume for Friday 16:00 UTC, price flat 0.00% (strength 11) |
| major spike | neutral | 56 | Jul 10, 03:49 PM | CRSP major volume spike: 587% of expected volume for Friday 15:00 UTC, price flat 0.08% (strength 56) |
EARNINGS signals are experimental: currently limited to neutral pre-earnings calendar awareness (no transcript analysis).
Market coverage
| Market | Exchange | Source | Asset record |
|---|---|---|---|
| CRSP | NASDAQ | alpaca | CRISPR Therapeutics AG Common Shares |
| CRSP | NASDAQ | alphavantage | CRISPR Therapeutics AG |
| CRSP | NASDAQ | fmp | CRISPR Therapeutics AG |
Recent insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jun 5, 2026 | Rommel Christian | Director | grant | 13,000 | — | — | 4 on EDGAR |
| Jun 5, 2026 | Fleming Harold Edward | Director | grant | 13,000 | — | — | 4 on EDGAR |
| Jun 5, 2026 | George Simeon | Director | grant | 13,000 | — | — | 4 on EDGAR |
| Jun 5, 2026 | Behbahani Ali | Director | grant | 13,000 | — | — | 4 on EDGAR |
| Jun 5, 2026 | Mahatme Sandesh | Director | grant | 13,000 | — | — | 4 on EDGAR |
| Jun 5, 2026 | High Katherine A | Director | grant | 13,000 | — | — | 4 on EDGAR |
| Jun 5, 2026 | Fardis Maria | Director | grant | 13,000 | — | — | 4 on EDGAR |
| Jun 5, 2026 | Greene John | Director | grant | 13,000 | — | — | 4 on EDGAR |
| Jun 5, 2026 | Treco Douglas A | Director | grant | 13,000 | — | — | 4 on EDGAR |
| Jun 5, 2026 | Morrison Briggs | Director | grant | 13,000 | — | — | 4 on EDGAR |
| May 29, 2026 | Patel Naimish | Chief Medical Officer | grant | 22,000 | — | — | 4 on EDGAR |
| May 29, 2026 | KASINGER JAMES R. | General Counsel and Secretary | grant | 17,000 | — | — | 4 on EDGAR |
| May 29, 2026 | Prasad Raju | Chief Financial Officer | grant | 19,500 | — | — | 4 on EDGAR |
| May 28, 2026 | Patel Naimish | Chief Medical Officer | exercise | 10,000 | — | — | 4 on EDGAR |
| Mar 20, 2026 | KASINGER JAMES R. | General Counsel and Secretary | exercise | 6,250 | — | — | 4 on EDGAR |
| Mar 20, 2026 | Patel Naimish | Chief Medical Officer | grant | 38,499 | — | — | 4 on EDGAR |
| Mar 20, 2026 | Prasad Raju | Chief Financial Officer | exercise | 6,250 | — | — | 4 on EDGAR |
| Mar 20, 2026 | Kulkarni Samarth | Chief Executive Officer | exercise | 19,687 | — | — | 4 on EDGAR |
| Mar 14, 2026 | Prasad Raju | Chief Financial Officer | exercise | 10,000 | — | — | 4 on EDGAR |
| Mar 14, 2026 | Patel Naimish | Chief Medical Officer | exercise | 8,125 | — | — | 4 on EDGAR |
Source: SEC filings via QuantConomy. Not investment advice.
Query CRSP context like a database.
These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.
More: All insider trades · How to read a Form 4 · API access